Manhattan Associates (MANH) EVP receives new stock-based awards

Rhea-AI Filing Summary

Manhattan Associates EVP, Americas Sales Robert G. Howell reported stock-based compensation transactions. On January 22, 2026, he acquired 10,353 and 2,809 shares of common stock at a price of $0.00 per share through grant or award acquisitions under the company’s stock incentive plan.

Footnotes explain these come from performance-based restricted stock units granted on January 23, 2025 and July 30, 2025, vesting 25% on February 28, 2026 and 25% on January 31 of each following year until fully vested. As of the filing date, he beneficially owns 179,173 shares of common stock, including outstanding and unvested RSUs and unvested performance-based RSUs.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Howell Robert G

(Last) (First) (Middle)

2300 WINDY RIDGE PARKWAY

10TH FLOOR

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MANHATTAN ASSOCIATES INC [ MANH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Americas Sales

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/22/2026		A		10,353(1)	A	$0.0000	170,898	D
Common Stock	01/22/2026		A		2,809(2)	A	$0.0000	173,707(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are performance-based restricted stock units granted on January 23, 2025 under the Company's stock incentive plan, vesting 25% on February 28, 2026 and 25% on January 31st of each year thereafter until fully vested.

2. These are performance-based restricted stock units granted on July 30, 2025 under the Company's stock incentive plan, vesting 25% on February 28, 2026 and 25% on January 31st of each year thereafter until fully vested.

3. As of the filing date of this Form 4, the Reporting Person beneficially owns 179,173 shares of common stock of the Issuer, which includes outstanding and unvested RSUs and unvested performance-based RSUs.

	/s/ David M. Eaton, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MANH executive Robert G. Howell report on this Form 4?

Robert G. Howell reported acquiring common stock of MANH through stock awards. On January 22, 2026, he received two grant or award acquisitions totaling 13,162 shares at $0.00 per share, reflecting stock-based compensation under the company’s stock incentive plan.

How many Manhattan Associates (MANH) shares did Robert G. Howell acquire in this filing?

Robert G. Howell acquired 10,353 and 2,809 shares of MANH common stock. Both transactions were coded as grant or award acquisitions at $0.00 per share, indicating stock-based compensation rather than open-market purchases for cash.

What is the vesting schedule for the MANH performance-based RSUs reported by Robert G. Howell?

The performance-based RSUs vest 25% on February 28, 2026 and 25% on January 31 of each year thereafter. This schedule applies to RSUs granted on January 23, 2025 and July 30, 2025 under Manhattan Associates’ stock incentive plan until fully vested.

How many Manhattan Associates (MANH) shares does Robert G. Howell beneficially own after these transactions?

As of the Form 4 filing date, Robert G. Howell beneficially owns 179,173 MANH common shares. This figure includes both outstanding and unvested restricted stock units and unvested performance-based RSUs, reflecting his total reported economic interest in the issuer’s stock.

What role does Robert G. Howell hold at Manhattan Associates (MANH) in this Form 4?

In this Form 4, Robert G. Howell is identified as EVP, Americas Sales of Manhattan Associates. The reported stock transactions relate to his executive compensation, involving performance-based restricted stock units granted under the company’s stock incentive plan.

Were the MANH shares in Robert G. Howell’s Form 4 bought on the open market?

The MANH shares were not reported as open-market purchases. Both transactions are coded as grant or award acquisitions at $0.00 per share, indicating equity compensation awards rather than cash purchases on the open market.